Literature DB >> 2388203

Longitudinal study of clinical and radiological progression in psoriatic arthritis.

D D Gladman1, F Stafford-Brady, C H Chang, K Lewandowski, M L Russell.   

Abstract

Our aim was to document the progression of psoriatic arthritis in 126 patients prospectively evaluated for a minimum of 5 years. Clinical and laboratory variables and radiographs of the hands and feet, recorded at first and last assessment, were compared to document change in the degree of joint inflammation and damage. During followup there was a significant increase in the use of a number of therapeutic modalities, in particular, gold, PUVA, retinoids and intraarticular glucocorticoid injections. Evidence of inflammatory arthritis was decreased at last assessment relative to presentation. The rate of progression of joint damage, calculated by the ratio of the number of damaged joints to the duration of arthritis in years, actually decreased during followup from 1.97/year to 0.5/year. Nevertheless the proportion of patients with at least 5 damaged joints doubled from 19 to 41% during the study. Thus, despite active treatment and a reduction in joint inflammation and in rate of damage, psoriatic arthritis may be a progressively deforming arthritis, even during 5 years of followup.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2388203

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  43 in total

1.  TNFalpha therapy in psoriatic arthritis and psoriasis.

Authors:  P Mease
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

Review 2.  Ultrasound in psoriatic arthritis. Can it facilitate a best routine practice in the diagnosis and management of psoriatic arthritis?

Authors:  Marwin Gutierrez; Antonella Draghessi; Chiara Bertolazzi; Gian Luca Erre; Lina Maria Saldarriaga-Rivera; Alberto López-Reyes; Javier Fernández-Torres; Marcelo J Audisio; Carlos Pineda
Journal:  Clin Rheumatol       Date:  2015-08-23       Impact factor: 2.980

Review 3.  Psoriatic arthritis and imaging.

Authors:  P A Ory; D D Gladman; P J Mease
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 4.  Review of clinical registries of psoriatic arthritis: lessons learned?: value for the future?

Authors:  Dafna D Gladman; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

5.  The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.

Authors:  A Kavanaugh; C E Antoni; D Gladman; S Wassenberg; B Zhou; A Beutler; G Keenan; G Burmester; D E Furst; M H Weisman; J R Kalden; J Smolen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

Review 6.  Real-world effectiveness of anti-TNF switching in psoriatic arthritis: a systematic review of the literature.

Authors:  Soumya M Reddy; Sheila Crean; Amber L Martin; Meghan D Burns; Jacqueline B Palmer
Journal:  Clin Rheumatol       Date:  2016-10-12       Impact factor: 2.980

7.  Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial.

Authors:  D D Gladman; P J Mease; M A Cifaldi; R J Perdok; E Sasso; J Medich
Journal:  Ann Rheum Dis       Date:  2006-10-17       Impact factor: 19.103

Review 8.  Radiographic scoring methods in rheumatoid arthritis and psoriatic arthritis.

Authors:  Fausto Salaffi; Marina Carotti; Giacomo Beci; Marco Di Carlo; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2019-02-09       Impact factor: 3.469

9.  Psoriatic arthritis: pharmacoeconomic considerations.

Authors:  Ignazio Olivieri; Lorenzo Giovanni Mantovani; Salvatore D'Angelo; Angela Padula; Simona de Portu
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

10.  The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate.

Authors:  Raffaele Scarpa; Rosario Peluso; Mariangela Atteno; Francesco Manguso; Angelo Spanò; Salvatore Iervolino; Matteo Nicola Dario Di Minno; Luisa Costa; Antonio Del Puente
Journal:  Clin Rheumatol       Date:  2007-11-21       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.